Showing results (151-160 of 172) with videos related to
Sort By:
Pageof 18
Atherosclerosis Plus|July 3, 2025
Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi surveyAlexander R M Lyons, Frederick J Raal, Brett S Mansfield, et al.Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.Circulation|November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.Journal of Clinical Medicine|September 9, 2023
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future DirectionsFrancesco Perone, Marco Bernardi, Alban Redheuil, et al.Journal of Hypertension|April 11, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatmentVasilios Kotsis, Jens Jordan, Dragan Micic, et al.Atherosclerosis|June 1, 2022
The spoils of war and the long-term spoiling of health conditions of entire nationsEliano P Navarese, Klaudyna Grzelakowska, Francesco Mangini, et al.Journal of Hypertension|April 14, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directionsVasilios Kotsis, Konstantinos Tsioufis, Christina Antza, et al.Atherosclerosis|June 4, 2026
Safety of very low LDL-cholesterol: Ten common concerns, misconceptions, and evidence-based clarificationsLuz Clemencia Zárate-Correa, Ángel García-Peña, Sergio Emanuel Kaiser, et al.Atherosclerosis|October 2, 2018
What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?Meral Kayikcioglu, Lale Tokgozoglu, Volkan Dogan, et al.JAMA Cardiology|April 30, 2020
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER TrialBrian A Bergmark, Michelle L O'Donoghue, Sabina A Murphy, et al.Pageof 18